相关实验视频
Updated: Jan 10, 2026
09:25
Quantifying Subcellular Ubiquitin-proteasome Activity in the Rodent Brain
Published on: May 21, 2019
7.1K
大脑疾病中的乌比奎丁-蛋白质体系统:致病途径,后翻译调整和治疗边界
Rohan Gupta1,2, M Yasmin Begum3, Reetesh Kumar4
1Department of Biotechnology & Bioengineering, School of Biosciences and Technology, Galgotias University, Greater Noida, Uttar Pradesh, 203201, India. rohan.gupta@galgotiasuniversity.edu.in.
概括
在神经退行性疾病 (NDD) 中,ubiquitination和deubiquitination酶至关重要. 这些过程的失调导致有毒蛋白质的积累和细胞功能受损,为NDD提供了新的治疗点.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 神经科学是一个神经科学.
背景情况:
- 乌比基化是一种重要的酶化过程,调节蛋白质降解,贩运和信号传递,对细胞平衡至关重要.
- 无素-蛋白酶体系统 (UPS) 的失调与各种疾病有关,包括神经退行性疾病 (NDD).
- UPS影响炎症和亚细胞局部化,影响细胞健康.
研究的目的:
- 探索在NDD中泛化和脱泛化酶的作用.
- 为了突出其参与蛋白质聚合,线粒体功能障碍,神经炎症和突触改变.
- 审查新兴的治疗策略,以恢复NDD中的蛋白质静止.
主要方法:
- 关于ubiquitination, deubiquitination和NDDs的文献的审查.
- 专注于特定的酶,如E3结合酶 (例如帕金,CHIP) 和二维基因酶 (例如USP14,UCHL1).
- 分析翻译后修改 (PTM) 和它们对UPS活动的影响.
主要成果:
- 关键酶的突变破坏了蛋白质稳定,导致神经毒性蛋白质 (Aβ,tau,α-synuclein,mHtt) 的积累.
- 在NDD中,乌比基化途径与蛋白质聚合,线粒体损伤,神经炎症和突触功能障碍有关.
- 化和乙化等PTM进一步调节UPS活动和疾病进展.
结论:
- 通过治疗干预恢复蛋白质静止是NDD治疗的一个有希望的策略.
- 向泛化和脱化酶为新型NDD疗法提供了潜在的潜力.
- 新兴的策略包括小分子,天然化合物,基于RNA的疗法和饮食干预.
相关概念视频
01:13The Proteasome
1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
02:18The Proteasome
10.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.0K
02:18The Proteasome
4.4K
4.4K
02:58Regulated Protein Degradation
8.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.7K
02:58Regulated Protein Degradation
3.1K
3.1K
02:04Covalently Linked Protein Regulators
8.6K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
8.6K